People with multiple myeloma who once spent hours connected to an intravenous drip for daratumumab can now receive the same drug through a brief injection under the skin. The shift from IV to ...
Delivering Sarclisa via an under-the-skin injection may improve the quality of life of patients with pretreated relapsed, refractory multiple myeloma, according to recent research. Treatment with ...
Black patients may be more affected by certain side effects from Talvey compared with White patients with multiple myeloma, an expert told CURE®. Black patients with multiple myeloma experience ...
What Is Sarclisa Escena and why does it matter? The FDA has approved Sarclisa Escena (isatuximab-irfc) for adults with a type of bone marrow cancer called multiple myeloma. This medicine is used along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results